Literature DB >> 14734628

Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions.

Jun Z Li1, Marquis P Vawter, David M Walsh, Hiroaki Tomita, Simon J Evans, Prabhakara V Choudary, Juan F Lopez, Abigail Avelar, Vida Shokoohi, Tisha Chung, Omar Mesarwi, Edward G Jones, Stanley J Watson, Huda Akil, William E Bunney, Richard M Myers.   

Abstract

Studies of gene expression abnormalities in psychiatric or neurological disorders often involve the use of postmortem brain tissue. Compared with single-cell organisms or clonal cell lines, the biological environment and medical history of human subjects cannot be controlled, and are often difficult to document fully. The chance of finding significant and replicable changes depends on the nature and magnitude of the observed variations among the studied subjects. During an analysis of gene expression changes in mood disorders, we observed a remarkable degree of natural variation among 120 samples, which represented three brain regions in 40 subjects. Most of such diversity can be accounted for by two distinct expression patterns, which in turn are strongly correlated with tissue pH. Individuals who suffered prolonged agonal states, such as with respiratory arrest, multi-organ failure or coma, tended to have lower pH in the brain; whereas those who experienced brief deaths, associated with accidents, cardiac events or asphyxia, generally had normal pH. The lower pH samples exhibited a systematic decrease in expression of genes involved in energy metabolism and proteolytic activities, and a consistent increase of genes encoding stress-response proteins and transcription factors. This functional specificity of changed genes suggests that the difference is not merely due to random RNA degradation in low pH samples; rather it reflects a broad and actively coordinated biological response in living cells. These findings shed light on critical molecular mechanisms that are engaged during different forms of terminal stress, and may suggest clinical targets of protection or restoration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734628     DOI: 10.1093/hmg/ddh065

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  98 in total

1.  Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders.

Authors:  André S L M Antunes; Valéria de Almeida; Fernanda Crunfli; Victor C Carregari; Daniel Martins-de-Souza
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Transcriptional profiling of the developing rat brain reveals that the most dramatic regional differentiation in gene expression occurs postpartum.

Authors:  John D H Stead; Charles Neal; Fan Meng; Yongjia Wang; Simon Evans; Delia M Vazquez; Stanley J Watson; Huda Akil
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

3.  Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders.

Authors:  M P Vawter; H Tomita; F Meng; B Bolstad; J Li; S Evans; P Choudary; M Atz; L Shao; C Neal; D M Walsh; M Burmeister; T Speed; R Myers; E G Jones; S J Watson; H Akil; W E Bunney
Journal:  Mol Psychiatry       Date:  2006-04-25       Impact factor: 15.992

4.  Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder.

Authors:  Xiujun Sun; Jun-Feng Wang; Michael Tseng; L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2006-05       Impact factor: 6.186

Review 5.  Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research.

Authors:  Akiko Hayashi-Takagi; Marquis P Vawter; Kazuya Iwamoto
Journal:  Biol Psychiatry       Date:  2013-10-18       Impact factor: 13.382

6.  Gene expression profiling of neurochemically defined regions of the human brain by in situ hybridization-guided laser capture microdissection.

Authors:  René Bernard; Ilan A Kerman; Fan Meng; Simon J Evans; Irmgard Amrein; Edward G Jones; William E Bunney; Huda Akil; Stanley J Watson; Robert C Thompson
Journal:  J Neurosci Methods       Date:  2008-11-25       Impact factor: 2.390

7.  Dysregulation of the fibroblast growth factor system in major depression.

Authors:  S J Evans; P V Choudary; C R Neal; J Z Li; M P Vawter; H Tomita; J F Lopez; R C Thompson; F Meng; J D Stead; D M Walsh; R M Myers; W E Bunney; S J Watson; E G Jones; H Akil
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-13       Impact factor: 11.205

Review 8.  Postmortem brain: an underutilized substrate for studying severe mental illness.

Authors:  Robert E McCullumsmith; John H Hammond; Dan Shan; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-10-04       Impact factor: 7.853

9.  Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain.

Authors:  Winnie S Liang; Travis Dunckley; Thomas G Beach; Andrew Grover; Diego Mastroeni; Douglas G Walker; Richard J Caselli; Walter A Kukull; Daniel McKeel; John C Morris; Christine Hulette; Donald Schmechel; Gene E Alexander; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Physiol Genomics       Date:  2006-10-31       Impact factor: 3.107

10.  Can early myocardial infarction-related deaths be diagnosed using postmortem urotensin receptor expression levels?

Authors:  Mustafa Talip Sener; Emre Karakus; Zekai Halici; Erol Akpinar; Atilla Topcu; Ahmet Nezih Kok
Journal:  Forensic Sci Med Pathol       Date:  2014-06-18       Impact factor: 2.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.